Dyne Therapeutics, Inc.

NasdaqGS:DYN Stock Report

Market Cap: US$3.3b

Dyne Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:DYN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Sep 24SellUS$309,248Richard ScalzoIndividual9,596US$32.63
04 Sep 24BuyUS$1,057,216John CoxIndividual32,000US$33.09
11 Mar 24SellUS$223,465Joshua BrummIndividual8,618US$25.93
08 Mar 24SellUS$725,344Susanna HighIndividual27,199US$27.41
01 Mar 24SellUS$513,825Atlas Venture L.P.Company17,099US$30.05
28 Feb 24SellUS$2,166,797Atlas Venture L.P.Company89,407US$25.25
23 Feb 24SellUS$848,662Atlas Venture L.P.Company37,386US$22.70
09 Jan 24BuyUS$29,999,988Forbion Capital Partners B.V.Company1,714,285US$17.50

Insider Trading Volume

Insider Buying: DYN insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of DYN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders313,4330.285%
Hedge Funds6,387,1385.8%
VC/PE Firms19,993,46818.2%
Institutions83,354,82675.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.5%.


Top Shareholders

Top 25 shareholders own 86.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.99%
Atlas Venture L.P.
8,020,136US$261.3m0%24.87%
7.36%
BlackRock, Inc.
7,386,988US$240.7m37.1%no data
6.36%
RTW Investments, LP
6,387,138US$208.1m107%3.1%
6.03%
RA Capital Management, L.P.
6,049,204US$197.1m22.1%2.22%
5.9%
Forbion Capital Partners B.V.
5,924,128US$193.0m-24.5%32.03%
5.3%
FMR LLC
5,318,962US$173.3m65.3%0.01%
4.7%
The Vanguard Group, Inc.
4,718,054US$153.7m37.1%no data
4.61%
Janus Henderson Group plc
4,623,824US$150.6m72.8%0.06%
4.3%
Citadel Advisors LLC
4,316,006US$140.6m1.45%0.14%
3.98%
Deep Track Capital, LP
4,000,000US$130.3m-12.2%3.52%
3.31%
Adage Capital Management, L.P.
3,328,000US$108.4m43.1%0.19%
3.19%
State Street Global Advisors, Inc.
3,200,969US$104.3m-23.7%no data
2.64%
TCG Crossover Management, LLC
2,650,150US$86.3m0%7.5%
2.36%
T. Rowe Price Group, Inc.
2,366,069US$77.1m109%0.01%
2.17%
VR Adviser, LLC
2,173,913US$70.8m0%2.9%
2.07%
Holocene Advisors, LP
2,076,352US$67.6m0%0.27%
1.98%
Goldman Sachs Group, Investment Banking and Securities Investments
1,989,206US$64.8m27.8%0.03%
1.77%
Geode Capital Management, LLC
1,774,653US$57.8m35.7%no data
1.68%
Franklin Resources, Inc.
1,685,427US$54.9m-3.11%0.02%
1.63%
Vivo Capital, LLC
1,635,136US$53.3m0%4.04%
1.62%
Sofinnova Investment, Inc.
1,625,703US$53.0m-16.1%3.15%
1.56%
MPM BioImpact LLC
1,561,496US$50.9m-54.8%28.86%
1.51%
Artal Group S.A.
1,516,960US$49.4m-0.07%1.17%
1.32%
Jennison Associates LLC
1,327,222US$43.2m9.91%0.03%
1.23%
Woodline Partners LP
1,233,908US$40.2m76.8%0.37%